Keith Michael Gottesdiener Prime Medicine, Inc. (PRME) insider trading activity

Keith Michael Gottesdiener is Director of Prime Medicine, Inc.. Currently has a direct ownership of 2.31 Million shares of PRME, which is worth approximately $7.39 Million. The most recent transaction as insider was on Jun 05, 2024, when has been sold 250,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.31M

0% 3M change

9.76% 12M change

Total Value Held $7.39 Million

Keith Michael Gottesdiener Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 05 2024	SELL Bona fide gift	-	250,000 Reduced 9.76%	2,310,837 Common Stock
Nov 11 2023	SELL Bona fide gift	-	7,500 Reduced 0.29%	2,560,837 Common Stock

Also insider at

ICPT

INTERCEPT PHARMACEUTICALS, INC. Healthcare

Director

KMG